CM
SOLV icon

Crestline Management’s Solventum SOLV Stock Holding History

Crestline Management’s Portfolio SOLV Stock Details SOLV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,512
Closed -$364K – 688
2024
Q4 		$364K Sell
5,512
-2,753
-33% -$193K 0.01% 589
2024
Q3 		$576K Buy
+8,265
New +$497K 0.03% 349

Other funds holding SOLV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TFM
Trian Fund Management New York $3.86B AUM 26.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
IFP
Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Crestline Management's SOLV Position: Q1 2025 in Review

Crestline Management sold out of Solventum (SOLV) in Q1 2025, closing a stake of 5,512 shares — an estimated $364K sold.

Crestline Management first reported a position in SOLV in Q3 2024 and held it in 2 quarters. The position peaked at $576K in Q3 2024. 914 funds tracked by Wall St. Rank hold SOLV as of Q1 2025.

  • Crestline Management reported no remaining Solventum position as of Q1 2025 after selling out during the quarter.
  • Crestline Management sold 5,512 Solventum shares in Q1 2025, an estimated $364K.
  • Crestline Management first reported a position in Solventum in Q3 2024 and held it in 2 quarters.
  • Crestline Management's Solventum position peaked at $576K in Q3 2024.
  • 914 funds tracked by Wall St. Rank held Solventum as of Q1 2025.

Based on Crestline Management's 13F filing for Q1 2025, filed 15 May 2025.